Altamira Therapeutics is based in Hamilton, Bermuda. It has raised $4M in total funding. Latest round: Post-IPO equity.
Altamira Therapeutics funding overview
Altamira Therapeutics is based in Hamilton, Bermuda. Altamira Therapeutics has raised $4M in total disclosed funding. That places its disclosed total in the $1M–$25M range. Its most recent disclosed round is a Post-IPO equity announced in January 2024. The round record for Altamira Therapeutics runs through 2024; nothing later has been disclosed.
Altamira Therapeutics at a glance
Total raised
$4M
Latest round
Post-IPO equity
Latest round date
January 2024
Headquarters
Hamilton, Bermuda
Frequently asked about Altamira Therapeutics funding
How much has Altamira Therapeutics raised?
Altamira Therapeutics has raised $4M in total disclosed funding across the rounds on record.
Who has invested in Altamira Therapeutics?
No investors are named on the public record for Altamira Therapeutics yet.
What was the latest Altamira Therapeutics funding round?
The most recent disclosed round is a Post-IPO equity, announced in January 2024.
Where is Altamira Therapeutics based?
Altamira Therapeutics is based in Hamilton, Bermuda.
When did Altamira Therapeutics last raise?
The last disclosed Altamira Therapeutics round closed in January 2024 at Post-IPO equity.
Altamira Therapeutics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Hamilton below to benchmark round size and investor mix.
